Experience

Abintus Bio, Inc.

• United States
• Biotechnology
• 1 - 100 Employee

• Founder, Chief Technology Officer

  • Oct 2022 - Present

  San Diego, California, United States

• Founder, SVP Head of CMC

  • May 2020 - Present

  San Diego, California, United States Driven by a bold founding vision: Empowering patients from within, Abintus is pioneering potentially curative, off-the-shelf genetic medicines that engineer cells directly inside the patient’s body, also termed in vivo. These therapies are based on Abintus' clinically proven Modular Delivery Platform (MDP). The company’s two initial, fit-for-purpose, In Vivo programs are: 1. Highly selective gene expression targeting cell type/state via synthetic biology (e.g., In Vivo CAR-NK/T/Treg, In… Show more Driven by a bold founding vision: Empowering patients from within, Abintus is pioneering potentially curative, off-the-shelf genetic medicines that engineer cells directly inside the patient’s body, also termed in vivo. These therapies are based on Abintus' clinically proven Modular Delivery Platform (MDP). The company’s two initial, fit-for-purpose, In Vivo programs are: 1. Highly selective gene expression targeting cell type/state via synthetic biology (e.g., In Vivo CAR-NK/T/Treg, In Vivo TCR-T) with applications across multiple gene delivery systems (e.g., AAV, lenti, adeno, retro) and therapeutic areas including leukemia, solid tumors and autoimmune disease. 2. Ability to engineer a diverse repertoire of active innate and adaptive immune cells (e.g., In Vivo CAR-X) with applications in lymphoma, solid tumors and autoimmune disease. Abintus is leveraging over 20 years and $275 million of prior technology advancement for in vivo engineering including the treatment of over 350 patients through Phase 3 registration trials. Abintus’ initial funding syndicate included Takeda Ventures and The Leukemia & Lymphoma Society’s Therapy Acceleration Program® (LLS TAP). Abintus Bio, Inc. (“Abintus”) is headquartered in San Diego. www.abintusbio.com.



Tocagen Inc.

• United States
• Biotechnology Research
• 1 - 100 Employee

• Vice President of Prod Dev and Manufacturing

  • Mar 2015 - May 2020

  San Diego County, California, United States

• Sr. Director Product Development and Manufacturing

  • Mar 2008 - Mar 2015


NovaRx
• Pharmaceutical Manufacturing
• 1 - 100 Employee
• Director of Manufacturing

  • Feb 2005 - Mar 2008

Oxford BioMedica, San Diego, USA
• Director and VP of Dev. and MFG

  • 2001 - 2004


Collateral Theraputics

• United States
• Biotechnology Research

• Senior Scientist

  • Apr 1999 - Apr 2001

  San Diego County, California, United States



Chiron Corporation

• United States
• Biotechnology
• 100 - 200 Employee

• Senior Scientist

  • Jun 1995 - Jun 1998

  San Diego, California


Viagene, Inc.
• Biotechnology
• Senior Scientist

  • 1991 - Jun 1995